E
Lyell Immunopharma, Inc. LYEL
$10.76 -$0.21-1.91% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -38.46% 133.33% -15.38% 36.00% -51.85%
Total Other Revenue -- -- -- -- --
Total Revenue -38.46% 133.33% -15.38% 36.00% -51.85%
Cost of Revenue -- -- -- -- --
Gross Profit -38.46% 133.33% -15.38% 36.00% -51.85%
SG&A Expenses -20.15% 4.09% 10.29% -24.11% -35.60%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -37.09% -27.60% -33.30% -150.00% -71.53%
Total Operating Expenses -15.98% 0.94% 4.52% -14.43% -21.83%
Operating Income 15.97% -0.93% -4.52% 14.45% 21.81%
Income Before Tax 6.82% 13.96% -262.62% 12.33% 28.30%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 6.82% 13.96% -262.62% 12.33% 28.30%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 6.82% 13.96% -262.62% 12.33% 28.30%
EBIT 15.97% -0.93% -4.52% 14.45% 21.81%
EBITDA 13.87% -4.15% -5.00% 15.04% 23.37%
EPS Basic 19.56% 25.87% -227.45% 14.04% 29.76%
Normalized Basic EPS 26.81% 10.88% 3.17% 14.23% 26.39%
EPS Diluted 19.56% 25.87% -227.45% 14.04% 29.76%
Normalized Diluted EPS 26.81% 10.88% 3.17% 14.23% 26.39%
Average Basic Shares Outstanding 15.84% 16.07% 10.74% 1.99% 2.08%
Average Diluted Shares Outstanding 15.84% 16.07% 10.74% 1.99% 2.08%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --